BeStock  

Invesco IVZ

US equityMarket cap rank #1295Asset Management
$26.51 −$1.26 (-4.54%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.73 +0.83%
Open$27.57
Prev close$27.77
Day range$26.31 – $27.68
Volume7.56M
Market cap$11.65B
P/E (TTM)–
Dividend yield3.21%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership97.6%+0.00 pts vs. prior quarter
Institutions holding835-2 vs. prior quarter
Insider trades (recent)29 buys / 21 sellsNet buying
Short interest3.62% of floatDays to cover 2.8 · as of 30 Oct 2026
Short-sale volume share22.7%5-day average of daily volume

Short-sale volume as % of daily volume

11%16%22%27%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$45.97M (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

−$32.1MSuper−$13.9MBig−$13.1MMid−$13.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 43.7% of shares outstanding.

Largest holders

  • Massachusetts Mutual Life Insurance Company18.52%
  • BlackRock8.93%
  • Vanguard Capital Management, LLC7.11%
  • Dimensional Fund Advisors4.74%
  • Vanguard Portfolio Management, LLC4.39%
  • AQR Capital Management4.14%
  • State Street Global Advisors3.86%
  • Geode Capital Management, LLC2.82%

By investor type

  • Mutual Fund58.85%
  • Private Company20.34%
  • Hedge Fund10.87%
  • Public Company4.10%
  • Government Pension Fund1.46%
  • Sovereign Wealth Fund1.19%
  • Individual/Insider0.69%
  • Family Office/Trust0.35%

Reported short interest has risen from 2.51% to 3.62% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
AQR Capital Management Hedge Fund 2026/Q4 +5,846,387 4.1%
Citadel Advisors LLC Hedge Fund 2026/Q4 +2,915,470 1.1%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q4 +1,617,557 1.2%
The Bank of Nova Scotia Public Company 2026/Q4 +1,386,002 0.3%
UBS Asset Management Mutual Fund 2026/Q4 +1,311,401 1.0%
Freestone Grove Partners LP Hedge Fund 2026/Q4 +1,218,661 0.3%
BNP Paribas Financial Markets SNC Private Company 2026/Q4 +1,052,120 0.4%
JPMorgan Chase & Co. Public Company 2026/Q4 +971,714 0.3%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q4 +822,110 4.4%
Walleye Capital LLC Hedge Fund 2026/Q4 +763,840 0.2%
Natixis S.A. Private Company 2026/Q4 +759,341 0.2%
Morgan Stanley Public Company 2026/Q4 +742,276 1.1%
Vanguard Capital Management, LLC Mutual Fund 2026/Q4 +695,860 7.1%
BMO Asset Management Mutual Fund 2026/Q4 +669,204 0.4%
Pacific Investment Management Company LLC Mutual Fund 2026/Q4 +667,589 0.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
15 Oct 2026 Shannon Johnston Senior MD & Chief Information and Operations Officer Derivative Exercise and Sale -12,526 $28.20 40,569
15 Oct 2026 Shannon Johnston Senior MD & Chief Information and Operations Officer Derivative Exercise and Retained +15,723 – 40,569
10 Sep 2026 Phoebe Wood Independent Non-Executive Director Open Market Disposition -3,000 $32.44 107,111
8 Sep 2026 Andrew Tak Lo Senior MD & Head of Asia Pacific Intent to Sell (Form 144) -100,840 $32.20 –
8 Sep 2026 Stephanie Butcher Senior MD & Co-Head of Investment Open Market Disposition -45,095 $32.28 10,205
8 Sep 2026 Andrew Tak Lo Senior MD & Head of Asia Pacific Open Market Disposition -143,370 $32.85 812,477
7 Sep 2026 Andrew Tak Lo Senior MD & Head of Asia Pacific Intent to Sell (Form 144) -42,530 $32.85 –
3 Sep 2026 Laura Dukes Senior MD & CFO Other Disposition -7,600 – 251,583
3 Sep 2026 Laura Dukes Senior MD & CFO Open Market Disposition -31,075 $33.16 251,583
30 Aug 2026 Stephanie Butcher Senior MD & Co-Head of Investment Derivative Exercise and Sale -30,760 $32.78 55,300
30 Aug 2026 Stephanie Butcher Senior MD & Co-Head of Investment Derivative Exercise and Retained +34,682 – 55,300
30 Aug 2026 Douglas Sharp Senior MD, Head of the Americas and EMEA & Chair of the Board of Invesco UK Derivative Exercise and Sale -22,213 $32.78 88,387
30 Aug 2026 Douglas Sharp Senior MD, Head of the Americas and EMEA & Chair of the Board of Invesco UK Derivative Exercise and Retained +48,272 – 88,387
1 Jul 2026 Jeffrey Kupor Senior MD & General Counsel Sale to Issuer -26,002 $27.01 125,818
1 Jul 2026 Andrew Tak Lo Senior MD & Head of Asia Pacific Derivative Exercise and Retained +116,754 – 955,847
1 Jul 2026 Andrew Schlossberg Chief Executive Officer Sale to Issuer -156,007 $27.01 742,708
1 Jul 2026 Laura Dukes Senior MD & CFO Sale to Issuer -52,003 $27.01 290,258
14 May 2026 G. Wagoner Chair of the Board Other Acquisition +8,112 – 122,870
14 May 2026 Thomas Finke Independent Non-Executive Director Other Acquisition +8,112 – 64,238
14 May 2026 William Glavin Independent Non-Executive Director Other Acquisition +8,112 – 81,084

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 15,909,802 3.6% 2.8
15 Oct 2026 16,400,988 3.7% 3.8
30 Sep 2026 16,111,028 3.6% 3.1
15 Sep 2026 13,080,822 3.0% 3.8
31 Aug 2026 12,375,805 2.8% 3.6
14 Aug 2026 11,091,933 2.5% 2.2

Discussion

No comments yet — be the first to weigh in on IVZ.

Sign in to join the discussion.

Scroll to Top